srep18514

Recombinant Human IL-33 Protein Summary

    Description
    Recombinant bioactive protein containing 160 amino acids for Human IL-33

    Source:E. coli
    Amino Acid Sequence:(O95760)

    Preparation
    Method
    >98% SDS-PAGE
    Source
    E. coli
    Protein/Peptide Type
    Recombinant Protein
    Gene
    IL33
    Purity
    >95%, by SDS-PAGE
    Endotoxin Note
    <0.1 ng/ug

Applications/Dilutions

    Theoretical MW
    18.1 kDa.
    Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.

Packaging, Storage & Formulations

    Storage
    Store at -20 to -80C. Avoid freeze-thaw cycles.
    Buffer
    Sterile filtered and lyophilized with no additives
    Concentration
    Lyoph
    Purity
    >95%, by SDS-PAGE
    Reconstitution Instructions
    Reconstitute in H2O to a concentration of 0.1-1.0 mg/ml. The solution can then be diluted into other aqueous buffers

Alternate Names for Recombinant Human IL-33 Protein

      C9orf26
      C9orf26chromosome 9 open reading frame 26 (NF-HEV)
      DKFZp586H0523
      DVS27
      DVS27-related protein
      IL1F11
      IL-1F11
      IL33
      IL-33
      interleukin 33
      Interleukin-1 family member 11
      interleukin-33
      NFHEV
      NF-HEV
      NF-HEVNFEHEV
      Nuclear factor from high endothelial venules
      RP11-575C20.2

Background

Recombinant human IL-33 produced from E. coli is a non-disulfide-linked homodimeric, non-glycosylated polypeptide chain consisting of 160 amino acids and having a total molecular mass of 18.1 kDa.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Tubacin

Related Post